|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2022
Hofheinz, Ralf-Dieter; Merx, Kirsten; Haag, Georg M.; Springfeld, Christoph; Ettrich, Thomas; Borchert, Kersten; Kretzschmar, Albrecht; Teschendorf, Christian; Siegler, Gabriele; Ebert, Matthias P.; Goekkurt, Eray; Mahlberg, Rolf; Homann, Nils; Pink, Daniel; Bechstein, Wolf; Reichardt, Peter; Flach, Hagen; Gaiser, Timo; Battmann, Achim; Oduncu, Fuat S.; Loose, Maria; Sookthai, Disorn; Pauligk, Claudia; Goetze, Thorsten O. und Al-Batran, Salah-Eddin
(2022):
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
In: Journal of Clinical Oncology, Bd. 40, Nr. 32: S. 3750-3762
Gruenwald, Viktor; Pink, Daniel; Egerer, Gerlinde; Schalk, Enrico; Augustin, Marinela; Deinzer, Christoph K. W.; Kob, Viola; Reichert, Dietmar; Kebenko, Maxim; Brandl, Stephan; Hahn, Dennis; Lindner, Lars H.; Hoiczyk, Mathias; Ringsdorf, Uta; Hanker, Lars C.; Hempel, Dirk; De Rivas, Beatriz; Wismann, Tobias und Ivanyi, Philipp
(2022):
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial.
In: Cancers, Bd. 14, Nr. 21, 5234
2021
Pink, Daniel; Andreou, Dimosthenis; Bauer, Sebastian; Brodowicz, Thomas; Kasper, Bernd; Reichardt, Peter; Richter, Stephan; Lindner, Lars H.; Szkandera, Joanna; Gruenwald, Viktor; Kebenko, Maxim; Kirchner, Marietta und Hohenberger, Peter
(2021):
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06).
In: Cancers, Bd. 13, Nr. 6, 1223
2019
Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Götze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Königsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Loehr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Fischer von Weikersthal, Ludwig; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Guentner, Martina; Hozaeel, Wael; Reichart, Alexander; Jaeger, Elke; Kraus, Thomas; Moenig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald und Hofheinz, Ralf D.
(2019):
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
In: Lancet, Bd. 393, Nr. 10184: S. 1948-1957
2017
Joensuu, Heikki; Wardelmann, Eva; Sihto, Harri; Eriksson, Mikael; Hall, Kirsten Sundby; Reichardt, Annette; Hartmann, Jörg T.; Pink, Daniel; Cameron, Silke; Hohenberger, Peter; Al-Batran, Salah-Eddin; Schlemmer, Marcus; Bauer, Sebastian; Nilsson, Bengt; Kallio, Raija; Junnila, Jouni; Vehtari, Aki und Reichardt, Peter
(2017):
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib An Exploratory Analysis of a Randomized Clinical Trial.
In: Jama Oncology, Bd. 3, Nr. 5: S. 602-609
2016
Joensuu, Heikki; Eriksson, Mikael; Hall, Kirsten Sundby; Reichardt, Annette; Hartmann, Jörg T.; Pink, Daniel; Ramadori, Giuliano; Hohenberger, Peter; Al-Batran, Salah-Eddin; Schlemmer, Marcus; Bauer, Sebastian; Wardelmann, Eva; Nilsson, Bengt; Sihto, Harri; Bono, Petri; Kallio, Raija; Junnila, Jouni; Alvegård, Thor und Reichardt, Peter
(2016):
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
In: Journal of Clinical Oncology, Bd. 34, Nr. 3:
244-U99